SCHEMBL8612643

SCHEMBL8612643

Cc1ccccc1-c1cc(NC(=N)NC=O)c2c(O)ccc(O)c2n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
HPGD P15428 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ATM Q13315 2/20 0.33
NFKB1 P19838 2/20 0.33
RAB9A P51151 2/20 0.33
NFKB2 Q00653 2/20 0.33
RELA Q04206 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 2/20 0.33
NPC1 O15118 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SDHB P21912 1/20 0.32
HTT P42858 2/20 0.32
MRE11 P49959 1/20 0.32
SIRT5 Q9NXA8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8620858 0.86 MAPT (0.41) MAPTHPGDMEN1KMT2AATM
SCHEMBL8616305 0.86 MEN1 (0.36) MAPTHPGDMEN1KMT2AATM
SCHEMBL8615227 0.85 MAPT (0.33) MAPTHPGDMEN1KMT2AATM
SCHEMBL8620296 0.85 HTT (0.35) MAPTHPGDMEN1KMT2AATM
SCHEMBL8619402 0.83 HTT (0.33) MAPTHPGDMEN1KMT2AATM
SCHEMBL8619771 0.83 HTT (0.35) MAPTHPGDMEN1KMT2AATM
SCHEMBL8620877 0.82 HTT (0.39) MAPTHPGDMEN1KMT2ARAB9A
SCHEMBL8619697 0.82 POLB (0.33) MAPTMEN1KMT2AHTTTP53
SCHEMBL8619171 0.82 MAPT (0.39) MAPTMEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL8615844 0.81 ADORA3 (0.36) MAPTMEN1KMT2ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed